Search Results 301-310 of 11041 for SC

  1. Squamous cell carcinoma of the skin - Diagnosis and treatment - Mayo Clinic

    This common skin cancer usually looks like a bump or a scaly sore. Learn about symptoms and treatment options, including freezing, lasers and surgery.

  2. Teamwork and a new nickname inspire patient through pancreatic cancer treatment - Mayo Clinic News Network

    When Walter "Dick" Whetstone leaves his home in central South Carolina, he's usually wearing a paw print or, at the least, his school colors of orange and ...

  3. Publications - Linda X. Yin, M.D. - Mayo Clinic

    ... SC, Gamez M, Holtzmann A, Mohammadi H, Garcia J, Chintakuntlawar A, Price KA, Fuentes Bayne HE, Rwigema JCM, Patel SH, McGee LA, Patel S, Janus JR, Chang B ...

  4. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative ...

  5. Clinical trials - Oncology (Medical)

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  6. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    Simmons SC, Taylor LJ, Marques MB, Williams LA. Rat Poisoning: A Challenging Diagnosis With Clinical and Psychological Implications. Lab Med. 2018 Jul 5; 49 ...

  7. Publications - Sonya Makhni, M.D., M.S. - Mayo Clinic

    Rojas JC, Fahrenbach J, Makhni S, Cook SC, Williams JS, Umscheid CA, Chin MH. Framework for Integrating Equity Into Machine Learning Models: A Case Study ...

  8. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID) - Mayo Clinic

    About this study. The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits ...

  9. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in ...

  10. Rectal Adenocarcinoma Clinical Trials

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...